Sodium Carbonate → HCID 89865820, compound
Reaction equation
Cl[C:2]1[N:7]=[CH:6][N:5]=[C:4]([NH:8][CH2:9][CH:10]([C:12]2[CH:17]=[CH:16][N:15]=[C:14]3[O:18][CH2:19][CH2:20][O:21][C:13]=23)[CH3:11])[CH:3]=1.[CH3:22][NH:23][C:24]1[N:29]=[CH:28][C:27](B2OC(C)(C)C(C)(C)O2)=[CH:26][N:25]=1.C([O-])([O-])=O.[Na+].[Na+]>CC(O)C.C(OCC)(=O)C.C1(P(C2C=CC=CC=2)[C-]2C=CC=C2)C=CC=CC=1.[C-]1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=C1.[Fe+2].Cl[Pd]Cl>[O:21]1[C:13]2[C:14](=[N:15][CH:16]=[CH:17][C:12]=2[C@H:10]([CH3:11])[CH2:9][NH:8][C:4]2[N:5]=[CH:6][N:7]=[C:2]([C:27]3[CH:26]=[N:25][C:24]([NH:23][CH3:22])=[N:29][CH:28]=3)[CH:3]=2)[O:18][CH2:19][CH2:20]1Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 4
Conditions
- Temperature
- 80 °C
Procedure
As shown in step 7-vi of Scheme 7, 6-chloro-N-[2-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-8-yl)propyl]pyrimidin-4-amine (410 mg) was dissolved in IPA (0.75 mL). N-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine (23 mg) was added, followed by the addition of 2M Na2CO3 (122 μL) and 1,1′-bis(diphenylphosphino)ferrocene]dichloropalladium(II), dichloromethane complex (7 mg). The reaction vessel was sealed and heated at 80° C. overnight. The mixture was cooled, diluted with ethyl acetate, washed with water, dried over Na2SO4, filtered, concentrated under reduced pressure and purified by reversed-phase HPLC, 5-50% ACN/H2O/0.1% TFA. Fractions containing pure product were collected, dissolved in MeOH, passed through a carbonate cartridge, and concentrated under reduced pressure to provide (S)—N6-(2-(2,3-dihydro-[1,4]dioxino[2,3-b]pyridin-8-yl)propyl)-N2′-methyl-[4,5′-bipyrimidine]-2′,6-diamine (Compound 462): ESMS=380.39 (M+H); 1H NMR (300 MHz, methanol-d4) δ 8.75 (s, 2H), 8.47 (s, 1H), 7.65 (d, J=5.3 Hz, 1H), 6.94 (d, J=5.2 Hz, 1H), 6.76 (s, 1H), 4.46-4.34 (m, 2H), 4.32-4.19 (m, 2H), 3.59 (ddd, J=12.0, 11.5, 7.3 Hz, 3H), 2.99 (s, 3H), 1.32 (d, J=6.7 Hz, 3H).
Workup
- customThe reaction vessel was sealed
- temperatureThe mixture was cooled
- washwashed with water
- dry with materialdried over Na2SO4
- filtrationfiltered
- concentrationconcentrated under reduced pressure
- custompurified by reversed-phase HPLC, 5-50% ACN/H2O/0.1% TFA
- additionFractions containing pure product
- customwere collected
- dissolutiondissolved in MeOH
- concentrationconcentrated under reduced pressure
Sources & evidence
- ORD record
- ord-67e00562cda44184ad69ee92e4fac8ea
- Source dataset
- uspto-grants-2016_06
- Patent number
- US09376448B2
Reaction notes
Loading…